Jay Thompson, DO
Orthopaedic Surgery · Steamboat Springs, CONPI 1821590787
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (43.7%), education and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 47.7% of the total. Reporting peaked in 2023 at $21,689 and has fallen 79.0% since, to $4,550 in 2025.
Across 159 payments — averaging $287.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$22K
- Pylant Medical$12K
- Stryker$6K
- Medacta USA, Inc.$4K
- Gemini Mountain Medical, LLC$494
- Smith+Nephew$466
- plus $812 from 7 others
What the payments were for
- Grants$20,00044%
- Travel & lodging$6,57214%
- Food & beverage$7,25716%
- Education$11,89226%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 23 | $21,825 |
| Pylant Medical | 21 | $12,148 |
| Stryker | 65 | $6,387 |
| Medacta USA, Inc. | 27 | $3,589 |
| Gemini Mountain Medical, LLC | 5 | $494 |
| Smith+Nephew | 8 | $466 |
| Cerapedics Inc. | 1 | $168 |
| Ossur Americas, Inc. | 3 | $156 |
| Miach Orthopaedics, Inc. | 1 | $149 |
| Biotissue Holdings Inc. | 1 | $142 |
| FX Shoulder Solutions, Inc | 1 | $107 |
| Integra Lifesciences Corporation | 1 | $51 |
| Bioventus LLC | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMIStem H Femoral Stems$2,326
- PRO$1,479
- GAMMA$1,079
- AMISTEM$628
- PANGEA$582
- HOFFMANN$386
- MAKO$303
- AXSOS$302
- INSPACE$174
- CHARLOTTE$172
- AEQUALIS ASCEND FLEX$170
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$168
- AEQUALIS REVERSED II$167
- ASNIS$155
- Bioinductive Implant with Arthroscopic Delivery System - Medium$142
- T2 ALPHA$142
- M-Vizion Femoral Revision System$129
- VARIAX$127
- Unloader One X$114
- AEQUALIS PERFORM REVERSED$112
How this compares
$45,721 in reported general payments places this provider in the 85th percentile of 383 orthopaedic surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 51 | $740 |
| Oxycodone Hcl | 49 | $248 |
| Ondansetron Hcl | 42 | $159 |
| Cephalexin | 45 | $86 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Steamboat Springs
- Joel MattaVail$21M
- Douglas DennisDenver$16.8M
- Brian HaasDenver$5.1M
- Theodore SchlegelGreenwood Village$5M
- Charlie YangDenver$3.6M
- Robert GreenhowLone Tree$2.8M
- David LoucksLone Tree$2.7M
- Robert BessGreenwood Village$1.8M
- Bharat DesaiGolden$1.4M
- Kris AldenBasalt$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.